Anixa Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Anixa Biosciences, Inc.‘s stocks are currently a part of 27 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 1.36M shares of Anixa Biosciences, Inc.. Compared to the previous quarter, the number fell by -62.43% or -2.27M shares fewer. As for the holding position changes, 25.93% (7) of current hedge fund investors increased the number of shares held, 18.52% (5) of current holders sold a part of the shares held, and 18.52% (5) closed the holdings completely. 3 hedge funds are new holders of Anixa Biosciences, Inc. stock in Q1 2023, it is 11.11% of total holders.
Hedge funds holding Anixa Biosciences (Q4 2018 – Q1 2023)
| Q4 2018 | 13 |
|---|---|
| Q1 2019 | 14 |
| Q2 2019 | 14 |
| Q3 2019 | 15 |
| Q4 2019 | 14 |
| Q1 2020 | 15 |
| Q2 2020 | 18 |
| Q3 2020 | 20 |
| Q4 2020 | 20 |
| Q1 2021 | 27 |
| Q2 2021 | 30 |
| Q3 2021 | 34 |
| Q4 2021 | 41 |
| Q1 2022 | 40 |
| Q2 2022 | 43 |
| Q3 2022 | 40 |
| Q4 2022 | 48 |
| Q1 2023 | 27 |
Hedge funds changes in Anixa Biosciences positions (Q4 2018 – Q1 2023)
| Q4 2018 | 13 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2019 | 1 | 7 | 4 | 0 | 2 |
| Q2 2019 | 2 | 5 | 3 | 2 | 2 |
| Q3 2019 | 2 | 6 | 2 | 1 | 4 |
| Q4 2019 | 1 | 5 | 5 | 2 | 1 |
| Q1 2020 | 2 | 3 | 5 | 1 | 4 |
| Q2 2020 | 6 | 5 | 4 | 3 | 0 |
| Q3 2020 | 6 | 4 | 5 | 4 | 1 |
| Q4 2020 | 5 | 8 | 4 | 5 | -2 |
| Q1 2021 | 11 | 8 | 6 | 3 | -1 |
| Q2 2021 | 8 | 9 | 4 | 6 | 3 |
| Q3 2021 | 8 | 7 | 10 | 4 | 5 |
| Q4 2021 | 10 | 9 | 10 | 3 | 9 |
| Q1 2022 | 6 | 12 | 10 | 7 | 5 |
| Q2 2022 | 9 | 8 | 11 | 6 | 9 |
| Q3 2022 | 5 | 9 | 7 | 7 | 12 |
| Q4 2022 | 11 | 10 | 11 | 3 | 13 |
| Q1 2023 | 3 | 7 | 5 | 5 | 7 |
Hedge funds changes in Anixa Biosciences stock options (Q4 2018 – Q1 2023)
| Q4 2018 | 0 | 0 |
|---|---|---|
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 118,000 | 59,000 |
| Q3 2021 | 251,000 | 317,000 |
| Q4 2021 | 122,000 | 85,000 |
| Q1 2022 | 78,000 | 5,000 |
| Q2 2022 | 151,000 | 45,000 |
| Q3 2022 | 99,000 | 64,000 |
| Q4 2022 | 193,800 | 25,075 |
| Q1 2023 | 4,758,000 | 0 |